Alexander van Akkooi

27PUBLICATIONS
99CO-AUTHORS
Predictive and prognostic markersTumour immunologyMedical biotechnology not elsewhere classifiedCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 20, 2026
Past, Present and Future: The Role of Sentinel Lymph Node Biopsy (SLNB) for Merkel Cell Carcinoma.

|Mar 30, 2026
Optimal Follow-Up of Sentinel Node Positive Melanoma Patients?

Alexander C J van Akkooi, Tina J Hieken

|Feb 04, 2026
ASO Visual Abstract: Independent Dutch Validation Study of CP-GEP (Merlin Assay) for the Prediction of Nodal Metastasis and Long-Term Outcome in Primary Cutaneous Melanoma Patients.

Lisanne P Zijlker, Zahra Verwer, Bart A van der Wiel

|Jan 28, 2026
Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

Lotte L Hoeijmakers, Petros Dimitriadis, Steven C M A Wijnen

|Jan 23, 2026
ASO Visual Abstract: International Survey on Evidence for Index Lymph Node Surgery Following Neoadjuvant Systemic Therapy for Stage III Melanoma.

Elan Novis, Mervi Rautalin, Rodabe N Amaria

|Dec 18, 2025
Independent Dutch Validation Study of CP-GEP (Merlin Assay) for the Prediction of Nodal Metastasis and Long-Term Outcome in Patients with Primary Cutaneous Melanoma.

Lisanne P Zijlker, Zahra Verwer, Bart A van der Wiel

Pageof 5

Frequent Collaborators

7 joint publications

Michel W Wouters

6 joint publications

Georgina V Long

4 joint publications

Judith M Versluis

4 joint publications

Ellen Kapiteijn